AwardedCzechiaGoodsCZK 164,869,285
Léčivé přípravky s obsahem obinutuzumabu a brentuximab vedotinu
- Published
- Published 13 May 2025
- Deadline
- Closed 13 June 2025
Overview
Předmětem veřejné zakázky jsou průběžné dodávky léčivých přípravků s obsahem obinutuzumabu a brentuximab vedotinu po dobu 4 let dle aktuálních potřeb zadavatele.
Key details
- Country
- Czechia
- Status
- Awarded
- Category
- Goods
- Estimated value
- CZK 164,869,285
- Procedure
- Open
- SME suitable
- Yes
- Published
- 13 May 2025
- Deadline
- Closed
Antineoplastic agents
Award outcome
- Awarded value
- CZK 132,502,199
- Award date
- 20 June 2025
- Contract period
- 18 July 2025 → 17 July 2029
- ROCHE s.r.o.
- Takeda Pharmaceuticals Czech Republic s.r.o.
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
17 July 2025
Contract Notice
13 May 2025
Contracting authority
Fakultní nemocnice Hradec Králové
Procuring entityHradec Králové - Nový Hradec Králové, Czechia
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.